Wishing you and your a very happy holiday season!

Two UK clinical trials are underway, each with the goal to study the effectiveness of several drugs on patients suffering with pleural mesothelioma. The first trial “MESO 2,” is dedicated to studying a drug called “ganetespib.” Supported by Cancer Research UK, the National Institute for Health Research Cancer Research Network (NCRN), Synta Pharmaceuticals, and University  Continue Reading »

Malignant mesothelioma(s) are cancerous tumors of the lining of the pleura (lung and chest cavity), caused exclusively by asbestos exposure. Many believed that only long-term exposure to asbestos caused malignant mesothelioma, but it is now known that even short-term and second-hand exposure to asbestos dust can cause this aggressive and debilitating disease. The latency period  Continue Reading »

Crocidolite is one of six different fibrous minerals or varieties of the human carcinogen known as asbestos. This naturally occurring mineral consists of long fibers that are immensely strong and flexible, and it offers the best heat resistance of all forms of asbestos. Thanks to these defining features, crocidolite, also called “blue asbestos,”  was widely  Continue Reading »

Finding the right individual or family doctor can be challenging, but add a unique condition such as mesothelioma, and the task can seem daunting. The good news is it doesn’t have to be. If you or a loved one has been diagnosed with mesothelioma, you will find that the medical landscape is becoming increasingly lush  Continue Reading »